Hoth Therapeutics Inc (NASDAQ:HOTH) has a beta value of 0.52 and has seen 4.77 million shares traded in the recent trading session. The company, currently valued at $12.55M, closed the recent trade at $0.95 per share which meant it lost -$0.02 on the day or -2.24% during that session. The HOTH stock price is -300.0% off its 52-week high price of $3.80 and 38.95% above the 52-week low of $0.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.25 million shares traded. The 3-month trading volume is 8.92 million shares.
The consensus among analysts is that Hoth Therapeutics Inc (HOTH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.34.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Sporting -2.24% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the HOTH stock price touched $0.95 or saw a rise of 9.52%. Year-to-date, Hoth Therapeutics Inc shares have moved 27.38%, while the 5-day performance has seen it change -6.58%. Over the past 30 days, the shares of Hoth Therapeutics Inc (NASDAQ:HOTH) have changed -23.15%. Short interest in the company has seen 0.28 million shares shorted with days to cover at 0.26.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
The company’s shares have gained 8.28% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 27.96% over the past 5 years. Earnings growth for 2025 is a modest 46.59% while over the next 5 years, the company’s earnings are expected to increase by 27.65%.
HOTH Dividends
Hoth Therapeutics Inc is expected to release its next earnings report on 2025-Mar-27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Insiders own 0.92% of the company shares, while shares held by institutions stand at 3.53% with a share float percentage of 3.57%. Investors are also buoyed by the number of investors in a company, with Hoth Therapeutics Inc having a total of 13.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.29% shares in the company for having 38.8 shares of worth $37876.0 while later fund manager owns 35.02 shares of worth $34179.0 as of Jan 31, 2025, which makes it owner of about 0.27% of company’s outstanding stock.
